Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Axcel VI in connection with the three parallel acquisitions of Installationsgruppen, Ventab and Ventilationsprojekt
Mandate

Vinge advises Axcel VI in connection with the three parallel acquisitions of Installationsgruppen, Ventab and Ventilationsprojekt

October 16, 2020 Employment and Benefits Banking and Finance M&A EU, Competition and Regulatory Commercial Agreements

Vinge has advised Axcel VI in connection with the three parallel acquisitions of Installationsgruppen Partners AB, Ventab Partners AB and Ventilationsprojekt i Sverige AB, which creates a leading installation group within HVAC, sprinkler and building automation.

The newly formed group, by the name Currentum, has a turnover of approximately SEK 900 million with over 300 employees. The transaction is subject to customary regulatory approvals.

Vinge’s team consisted primarily of partner Christina Kokko and associates Karl Klackenberg, Hannah Kajlinger and Carl Fredrik Wachtmeister (M&A), partner Mikael Ståhl and associate Karl-Gustaw Tobola (Financing), Lisa Hörnqvist (Commercial Agreements), Isak Willborg (Construction), Ebba Svenburg (Employment), Olof Löfvenberg (Real Estate and Environment), Johan Wahlbom (Competition Law), and Viktoria Owetz Leyva (VDR-assistant).

 

Related

Vinge advises Sobro on its investment in Västkustens Konstruktionsbyrå

 Västkustens Konstruktionsbyrå has decided to broaden its ownership structure by bringing in Sobro as a new co-partner and majority shareholder. The founders will remain with the company as the CEO and CTO respectively, and as significant shareholders. Västkustens Konstruktionsbyrå is an engineering consultancy company based in Gothenburg with cutting-edge expertise in project management, civil engineering and design.
April 23, 2026

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of SEK 350 million before transaction costs.
April 22, 2026

Vinge has advised Alder on the establishment of Alder Strategic Opportunities Fund I and on a fund credit facility agreement in connection with the fundraising

 Vinge has advised Alder on the establishment of the continuation fund Alder Strategic Opportunities Fund I AB. In connection with the establishment, the fund acquires the portfolio companies SI and SMG from Alder II. Vinge also advised Alder on the entering into of a fund credit facility agreement with SEB.
April 20, 2026